DAFTAR PUSTAKA

Adams, H.P.; Zoppo, G.; Alberts, M.J.; Bhatt, D.L.; Brass, L.; Furlan, A. et al. 2007. Guidelines for The Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke.38:1655-1711 Antithrombotic Trialists Collaboration. 2002. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ;324:71-86 Appelros,P.; Nydevik,I.; Vittanen, M. 2003. Poor Outcome After First-Ever Stroke : Predictors for Death, Dependency, and Recurrent Stroke Within the First Year. Stroke. 34:122-126 Bhatt, D.L.; Fox, K.A.A.; Hacke, W.; Berger, P.B.; Black, H.R.; Boden, W.E. et al.2006. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med.354:1706-17 Blann, A.D.; Landray, M.J.; Lip, G.Y.H. 2003. An of overwiew of antithrombotic therapy. In : Lip,G.Y.H, Blann, A.D. ABC of Antithrombotic Therapy. BMJ Publishing Groups. Spain. P.10-13 Caplan, L.R. 2000. Caplans Stroke : A Clinical Approach. 3rd ed. ButterworthHeinemann.Boston Caprie Steering Committee. 1996. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk ischemic events (CAPRIE). The Lancet.348:1329-1339 Clarkson, M.R.; Brenner, B.M. 2005. Pocket Companion to Brenner & Rectors The Kidney. 7th ed. Elsevier Saunders.Philadelphia Davis, J.P.; Wong, A.A.; Schluter, P.J.; Henderson, R.D.; OSullivan, J.D.; Read, S.J. 2004. Impact of Premorbid Indernutrition on Outcome in Stroke Patients. Stroke. 35:1930-1934 Dewoto, H.R. 2007. Antikoagulan, Antitrombotik, Trombolitik dan Hemostatik, Dalam : Gunawan, S.G, Setiabudy, R, Nafrialdi, Elysabeth. (Editor).

Universitas Sumatera Utara

Farmakologi dan Terapi. Departemen Farmakologi dan Terapeutik Fakultas Kedokteran-Universitas Indonesia. Balai Penerbit FK-UI, Jakarta. Hal.813-814 Diener, H.C. 2006. Update on clopidogrel and dual anti-platelet therapy : neurology. European Heart Journal Supplements G, G15-G19 . Furie, K.L.; Kasner, S.E.; Adams, R.J.; Albers, G.W.; Bush, R.L.; Fagan, S.C. et al. 2010. Guidelines for the Prevention Stroke in Patients With Stroke or Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. 41:00-00 Gamboa, A.; Abraham, R.; Diedrich, A.; Shibao, C.; Paranjape, Y.S.; Farley, G.; Biaggioni, I.; 2005. Role of Adenosine and Nitric Oxide on the Mechanism of Action of Dipyridamole. Stroke.36:2170-2175 Gilroy, J. 2000. Basic Neurology. 3rd ed. McGraw-Hill. New York Goldstein, L.B.; Adams, R.; Alberts, M.J.; Appel, L.J.; Brass, L.M.; Bushnell, C.D. et al. 2006. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Counsil. Stroke.37:1583-1633 Gorelick, P.B.; Weisman, S.M.2005.Risk of Hemorrhagic Stroke With Aspirin UseAn Update. Stroke.36:1806-1807 Glader, E.; Stegmary, B.; Johansson, L.; Asberg, K.H.; Wester, P.O. 2001. Differences in Long-Term Outcome Between Patients Treated in Stroke Units and in General Wards. Stroke. 32:2124-2130 Gree, D.M.; Funk, S.E.; Reaven, N.L.; Ouzounelli, M.; Uman, G.C. 2008. Impact of Fever on Outcome in Patients With Stroke and Neurologic Injury. Stroke. 39:3029-3035 Hankey, G.J.; Hacke, W.; Easton, D.; Johnston, S.E.; Mas, J.L. et al. 2010. Effect Of Clopidogrel on the Rate and Functional Severity Stroke Among High Vascular Risk Patients. Stroke.41:1679-1683 Hills, N.K.; Johsnton, S.C. 2008. Trends in Usage of Alternative Antiplatelet Therapy After Stroke and Transient Ischemic Attack. Stroke.39:1228-1232 Johnson, M.H. and Kubal, W.S. 1999. Stroke. In : Lee, S.H., Rao, K.C.V.G. and Zimmermann, R.A. (eds) Cranial MRI and CT. 4th ed. Pp 557-598. McGraw-Hill. New York

Universitas Sumatera Utara

Johnston, K.C.; Connors, J.; Wagner, D.P.; Knaus, W.A.; Wang, X.Q.; Haley, C. 2000. A Predictive Risk Model for Outcomes of Ischemic Stroke. Stroke. 31:448-455 Johnston, K.C.; Wagner, D.P.; Haley, C.; Connors, J. 2002. Combined Clinical and Imaging Informationa as An early Stroke Outcome Measure. Stroke. 33:466-472 Katzung, B.G. 2003. Drugs Used in Disorders of Coagulation, In : Basic & Clinical Pharmacology. McGraw-Hill. 9th ed.p.775-776 Kim, H.H.; Liao, J.K. 2008. Translational Therapeutics of Dipyridamole. Stroke.28:s39-s42 Kwon, S.; Hatzema, A.G.; Duncan, P.W.; Lai, S.M. 2004. Disability Measures in Stroke. Stroke. 35:918-923 Lalouschek, W.; Lang, W.; Mullner, M. 2001. Current Strategies of Secondary Prevention After a Cerebrovascular Event. Stroke.32:2860-2866 Lee, J.H.; Kim, K.Y.; Lee, Y.K.; Park, S.Y.; Kim, C.D.; Lee, W.S. 2004. Cilostazol Prevent Focal Cerebral Ischemic Injury by Enchancing Casien Kinase 2 Phsoporylation and Supression of Phospatase and Tensin Homolog Deleted from Chromosome 10 Phosporylation in Rats. The Journal of Pharmacology and Experimental Theurapetics. 308:896-903 Lee, Y.S.; Bae, H.J.; Kang, D.W.; Les, S.H.; Yu, K.; Park, J.M. et al. 2011. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non Inferiority Trial. Cerebrovasc Dis;32:65-71 Lip, G.Y.H.; Kamath, S.; Robert, G.H. 2003. Antithrombotic therapy for Cerebrovascular disorders. In : Lip,G.Y.H, Blann, A.D. ABC of Antithrombotic Therapy. BMJ Publishing Groups. Spain. P.37-39 Meyer, B.C.; Hemmen, T.M.; Jackson, C.M.; Lyden, P.D. 2002. Modified National Institute of Health Stroke Scale for Use in Stroke Clinical Trials : Prospective Reliability and Validity. Stroke.33:1261-1266 Millan, M.; Sobrino, T.; Castellanos, M.; Nombela, F.; Arenillas, J.F.; Riva, E. et al. 2007. Increased Body Iron Stores are Associated with Poor Outcome After Thrombolytic Treatment in Acute Stroke. Stroke. 38: 90-95 Misbach, J. 1999. Stroke : Aspek Diagnostik, Patofisiologi,Manajemen. Balai Penerbit FK-UI. Jakarta

Universitas Sumatera Utara

Misbach, J. 2007. Pandangan Umum Mengenai Stroke. Dalam : Rasyid, A. dan Soertidewi, L. (eds). Unit Stroke. Manajemen Stroke Secara Komprehensif. Hal 1-9. Balai Penerbit Universitas Indonesia. Jakarta Ng, Y.S.; Stein, J.; Ning, M.M.; Schaeffer, R.M. 2007. Comparison of Clinical Characteristics And Functional Outcomes of Ischemic Stroke in Different Vascular Territories. Stroke. 38:2309-2314 Nguyen, T.A.; Diodati, J.G; Pharand, C. 2005. Resistance to Clopidogrel : A Review of The Evidence. J Am Coll Cardiol.45:1157-64 ODonnel, M.J.; Hankey, G.J.; Eikelboom, J.W. 2008. Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke. Stroke.39:1638-1646 Paul, S.L.; Sturm, J.W.; Dewey, H.M.; Donnn, G.A.; Mcdonell, R.A.; Thrift, A.G. 2005. Long-Term Outcome in the North East Melbourne Stroke Incidence Study. Stroke.36:2082-2086 Liesner, R.J and Machin, S.J. 2003. Platelet Disorders. In : Provan, D. ABC of Clinical Haematology second edition. BMJ Books, Spain. P.35-39 Harjono, R.M.; Hartono, A.; Japaries, W.; Kuswadji, S.; Maulany, R.F.; Setio, M. 2002. Kamus Kedokteran Dorland. Penerbit Buku Kedokteran. Jakarta Ropper, A.H. and Brown, R.H. 2005. Adams and Victors Principles of Neurology. 8th ed. McGraw-Hill. New York Rudd, A.G.; Hoffman,,A.; Lowe, D.; Person, M.G. 2005. Stroke unit Care and Outcome. Stroke.36:103-106 Sacco, R.L.; Elkind, M.S. 2000. Update on Antiplatelet Therapy for Stroke Prevention. Arch Intern Med.160:1579-1582 Schlegel, D.; Kolb, S.J.; Luciano, J.M.; Tovar, J.M.; Cucchiara, B.L.; Liebeskind, D.S.; Kasner, S.E. 2003. Utility of the NIH Stroke Scale as A Predictor of Hospital Disposition. Stroke.34:134-137 Shinohara, Y. 2006. Antiplatelet Cilostazol Is Effective in The Prevention of Pneumonia in Ischemic Stroke Patients in the Chronic Stage. Cerebrovasc Dis.22:57-60 Shinohara, Y.; Katayama, Y.; Uchiyama, S.; Yamaguchi T.; Honda, S.; Matsuoka, K. et al. 2010. Cilostazol for prevention of secondary stroke (CSPS 2) : an aspirin-controlled, double-blind, randomized non-inferiority trial. http : www.thelancet.com/neurology, 11 September 2010

Universitas Sumatera Utara

Sigit, J.I. dan Hanif A. 2003. Farmakologi dan Toksikologi. Edisi 3. Penerbit Buku Kedokteran EGC. Jakarta Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung. Medan Uchino, K.; Billheimer, D.; Cramer, S.C. 2001. Entry Criteria and Baseline Characteristics Predict Outcome in Acute Stroke Trials. Stroke. 32:909916 Weimar, C.; Kurth, T.; Kraywinkel, K.; Wagner, M.; Busse, O.; Haberl, R.L.; Diener, H.S. 2002. Assessment of Functioning and Disability After Ischemic Stroke. 33:2053-2059 Williams, L.S.; Yilmaz, E.Y.; Lopez-Yunez, A.M. 2000. Retrospective Assessment of Initial Stroke Severity With the NIH Stroke Scale. Stroke. 31:858-62 Wilterdink, J.L.; Bendixen, B.; Adams, H.P.; Woolson, R.F.; Clarke, W.L.; et al. 2001. Effect of Prior Aspirin Use on Stroke Severity in The Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke.32:2836-2840 Yoo, H.D.; Cho, H.Y.; Lee, Y.B. 2010. Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3AS, CYP2C19, and ABCB1. Br J Clin Pharmacol, 69:27-37 Yong, M.; Kaste, M. 2008. Dynamic of Hyperglicemia as A predictor of Stroke Outcome in The ECSS-Trial. Stroke. 39:2749-2755

Universitas Sumatera Utara